Related by context. Frequent words. (Click for all words.) 60 iclaprim 58 Clinical Trial Results 57 Epratuzumab 57 Carfilzomib 57 Dasatinib 56 Traficet EN 56 Pivotal Trial 56 Everolimus 56 Lenalidomide 56 Irinotecan 56 Ceftobiprole 56 Tygacil 55 Fidaxomicin 55 mTOR inhibitor 55 Pivotal Phase III 55 CYC# 55 Phase Ib clinical 55 Vandetanib 55 BAL# [001] 55 OncoVEX GM CSF 55 Voreloxin 55 bevacizumab Avastin 55 orally bioavailable 55 Cethromycin 55 Zolinza 55 Drug Candidate 55 Panzem R 55 Preclinical Data 55 voriconazole 55 Ofatumumab 55 Mipomersen 54 Combination Therapy 54 etravirine 54 liposomal formulation 54 PEG SN# 54 transcriptase inhibitor NNRTI 54 Rifaximin 54 calcineurin inhibitors 54 nosocomial pneumonia 54 BAY #-# 54 KNS # 54 daptomycin 54 Apixaban 54 RGB # 54 Pegasys ® 53 Pirfenidone 53 Metastatic Melanoma 53 Erlotinib 53 tocilizumab 53 phase IIa 53 Oritavancin 53 Nasal Spray 53 Phase III Clinical Trial 53 anticancer compound 53 pertuzumab 53 registrational trial 53 dalbavancin 53 Anastrozole 53 Sym# 53 Lamivudine 53 Patient Enrollment 53 Maraviroc 53 Trastuzumab 53 Crofelemer 53 axitinib 53 Oxaliplatin 53 dasatinib 52 Chronic Hepatitis C 52 GAMMAGARD LIQUID 52 Bortezomib 52 Sirolimus 52 injection USP 52 itraconazole 52 Pulmonary Arterial Hypertension 52 Amrubicin 52 GV# [001] 52 LY# [002] 52 Phase III Trial 52 Bevacizumab 52 Metastatic Colorectal Cancer 52 Adjuvant 52 FDA Accepts 52 Azedra 52 Urocidin 52 Naproxcinod 52 StemEx 52 antifungal agent 52 Tolerability 52 Immunogenicity 52 leukemia CLL 52 fulvestrant 52 humanized antibody 52 PARP inhibitor 52 Benign Prostatic Hyperplasia 52 HuMax CD# 52 ACHN 52 SEROQUEL XR 52 NVA# 52 elotuzumab 52 romidepsin 52 polymerase inhibitors